CEFRIC – CV
Advanced Antibiotic Combination for Effective Infection Management
CEFRIC-CV by Citric Labs is a powerful antibiotic tablet formulated with Cefpodoxime Proxetil IP 200 MG + Potassium Clavulanate Diluted IP 125 MG. This combination is widely prescribed for treating bacterial infections affecting the respiratory tract, urinary tract, skin, throat, and ENT region. CEFRIC-CV is trusted for its broad-spectrum antibacterial action and enhanced effectiveness against resistant bacterial strains.
Composition
- Cefpodoxime Proxetil IP 200 MG
- Potassium Clavulanate Diluted IP 125 MG
Key Benefits
- High-quality antibiotic formulation
- Excellent therapeutic effectiveness
- Manufactured under quality-controlled standards
- Suitable for PCD Pharma Franchise business
- Attractive packaging and market demand
Product Description
CEFRIC-CV contains Cefpodoxime Proxetil IP 200 MG + Potassium Clavulanate Diluted IP 125 MG, an effective antibiotic combination used for treating bacterial infections. Manufactured by Citric Labs, it is ideal for PCD Pharma Franchise and healthcare distribution.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
